Chicago, Israel Team Up to Clean Water
Chicago, Israel Team Up to Clean Water
July 3, 2013
Chicago Jewish News — A research agreement between the University of Chicago and Ben-Gurion University of the Negev was signed by BGU President Prof. Rivka Carmi and University of Chicago President Robert Zimmer recently in a ceremony at the Israeli President’s Residence in Jerusalem.
The two universities committed to collaborate on a research initiative designed to apply the latest discoveries in nanotechnology to create new water production and purification technologies for deployment in areas of the world where freshwater resources are scarce.
University of Chicago President Robert Zimmer and Ben-Gurion University of the Negev President Prof. Rivka Carmi sign a water research agreement with Chicago Mayor Rahm Emanuel and Israeli President Shimon Peres onlooking.
“Clean, plentiful water is a strategic issue in the Middle East and the world at large, and a central research focus of our university for more than three decades,” says BGU President Rivka Carmi.
“We believe that this partnership will enhance state-of-the-art science in both universities, while having a profound effect on the sustainable availability of clean water to people around the globe,” adds Prof. Carmi.
The Chicago-Israel effort began with the signing of a memorandum of understanding in Chicago in March to explore a research partnership that would innovate water production and purification technologies to meet a growing thirst for fresh water resources globally.
Leading the efforts are Dr. Matthew Tirrell, the Pritzker Director of UChicago’s Institute for Molecular Engineering, and Professor Moshe Gottlieb, BGU’s Frankel Professor of Chemical Engineering.
“In this collaboration we intend to take advantage of the great strides achieved over the last decade in nanotechnology, materials science, biology, and chemistry at both institutions, and the world-class facilities available at Argonne National Laboratory,” says Prof. Gottlieb.
“These new tools and insights afford a molecular-level approach to tackle an age-old human plight.”
Read more on the Chicago Jewish News website >>
Stories Like This
